Shores Rheumatology
Saint Clair Shores, Michigan, United States
Rheumatologist in St. Clair Shores, Michigan
29200 Harper Ave, St Clair Shores, MI 48081
About Shores Rheumatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Pfizer
3
Genentech, Inc.
2
Amgen
1
Celgene
1
Crescendo Bioscience
1
DePuy Mitek
1
Fidia Farmaceutici s.p.a.
1
Galapagos NV
1
Horizon Pharma Rheumatology LLC
1
Novartis Pharmaceuticals
1
Clinical Trials at Shores Rheumatology
During the past decade, Shores Rheumatology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 10 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)
2007-01-01
2013-09-01
Completed
1,026
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
2009-03-05
2012-11-14
Terminated
28
A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)
2008-12-01
2010-08-01
Completed
432
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
2011-12-01
2014-03-01
Completed
183
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Shores Rheumatology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Celgene"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shores Rheumatology"
#1 collaborator was "Biogen" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Shores Rheumatology
According to Clinical.Site data, the most researched conditions in "Shores Rheumatology" are
"Rheumatoid Arthritis" (5 trials), "Arthritis, Rheumatoid" (3 trials), "Arthritis" (1 trials), "Behçet's Syndrome" (1 trials) and "Giant Cell Arteritis" (1 trials). Many other conditions were trialed in "Shores Rheumatology" in a lesser frequency.
Clinical Trials Intervention Types at Shores Rheumatology
Most popular intervention types in "Shores Rheumatology" are "Drug" (12 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Methotrexate" (3 trials), "Allopurinol" (1 trials), "Anti-TNF-alpha" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Shores Rheumatology
The vast majority of trials in "Shores Rheumatology" are
17 trials for "All" genders.
Clinical Trials Status at Shores Rheumatology
Currently, there are NaN active trials in "Shores Rheumatology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Shores Rheumatology,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Shores Rheumatology, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".